Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nano TransMed is Scopus-indexed (Q1, CiteScore 15), DOAJ. Published by KeAi Publishing Communications Ltd..
Checked against the index lists dated .
ISSN 2790-6760Verify ISSN ↗2790-7384Verify ISSN ↗
Publisher: KeAi Publishing Communications Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 7 / 278 | 97th | Q1 |
| Medicine (miscellaneous) | 22 / 466 | 95th | Q1 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q1, CiteScore 15.
Nano TransMed is Q1 in Pharmacology (medical) (rank 7 of 278) and Q1 in Medicine (miscellaneous) (rank 22 of 466), by CiteScore 2025.
Nano TransMed is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 15, quartile Q1, 97th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.075, quartile Q1, with an H-index of 22.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Nano TransMed is published by KeAi Publishing Communications Ltd. Its print ISSN is 2790-6760 and its online ISSN is 2790-7384.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Nano TransMed has an h-index of 30 and a 2-year mean of 22.03 citations per paper (OpenAlex). Its Scopus CiteScore is 15, quartile Q1. On 2-year citations it ranks #1 of 271 Scopus journals in Pharmacology (medical).
Nano TransMed published 35 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2022–2026), authors are most often from China (39.9%), India (25.7%) and United States (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (8.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.